MedPath
HSA Approval

AXCEL KETOTIFEN SYRUP 1 mg/5 ml

SIN10544P

AXCEL KETOTIFEN SYRUP 1 mg/5 ml

AXCEL KETOTIFEN SYRUP 1 mg/5 ml

December 12, 1998

KOTRA PHARMA MARKETING

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantKOTRA PHARMA MARKETING

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R06AX17

ketotifen

Manufacturer Information

KOTRA PHARMA MARKETING

KOTRA PHARMA (M) SDN BHD

Active Ingredients

KETOTIFEN HYDROGEN FUMARATE EQV KETOTIFEN

1 mg/5 ml

Ketotifen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AXCEL KETOTIFEN SYRUP 1 mg/5 ml - HSA Approval | MedPath